Mu receptor antagonists (eg, naloxone) must be used in the treatment of opioid-induced respiratory depression. Psychostimulants (eg, methylphenidate) to treat opioid-induced sedation are recommended only when other methods have been tried first and failed.
The use of naloxone in association with oxycodone or methylnaltrexone to control OIC may be considered. While naloxegol has been shown to be highly effective in OIC, there are no data specific to persons with cancer.
Learn more about palliative management of cancer pain.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Winston W. Tan. Fast Five Quiz: Oncology Pain Management - Medscape - Jul 19, 2021.